Dr. Amish Vora

Dr. Amish Vora performs major interventions in the following specialities:

• Medical Oncology

• University of Mumbai, Mumbai (MBBS)
• Bombay Hospital Institute Of Medical Sciences (MD Paediatrics)
• N R C H, New Delhi (DNB Pediatrics)
• All India Institute of Medical Sciences, New Delhi (DM Medical Oncology)

• Awarded the Best Paper Award at International Society of Paediatric Oncology Asia, New Delhi (2002)
• Best Paper Award at Paediatric Haematology & Oncology Conference, New Delhi (1999)
• APJ Abdul Kalam Health Award for being an outstanding oncologist
• Awarded the Best Paper Award at International Society of Paediatric Oncology Asia, New Delhi (2002)
• Best Paper Award at Paediatric Haematology & Oncology Conference, New Delhi (1999)
• APJ Abdul Kalam Health Award for being an outstanding oncologist

• Prabhash K, Vora A, Limaye S, Sahoo T, Batra U, Patil S, et al. Treatment of advanced non-small-cell lung cancer: First line, maintenance, and second line– Indian consensus statement update(Under the aegis of Lung Cancer Consortium Asia, Indian Cooperative Oncology Network, Indian Society of Medical
• Bhutani M, Vora A, Kumar L, Kochupillai V. Lympho-hemopoietic Malignancies in India. Medical Oncology. 2002;19(3):141–52.
• Bhutani M, Kumar L, Vora A, Bhardwaj N, Pathak AK, Singh R, et al. Randomized study comparing 4?-epi-doxorubicin (Epirubicin) versus doxorubicin as a part of induction treatment in adult acute lymphoblastic leukemia. American Journal of Hematology. 2002 Nov 22;71(4):241–7.
• Seth T, Vora A, Bhutani M, Ganessan K, Jain P, Kumar R, et al. Acute Basophilic Leukemia with t(8;21). Leukemia & Lymphoma. 2004 Mar;45(3):605–8
• Prabhash K, Vora A, Limaye S, Sahoo T, Batra U, Patil S, et al. Treatment of advanced non-small-cell lung cancer: First line, maintenance, and second line– Indian consensus statement update(Under the aegis of Lung Cancer Consortium Asia, Indian Cooperative Oncology Network, Indian Society of Medical
• Bhutani M, Vora A, Kumar L, Kochupillai V. Lympho-hemopoietic Malignancies in India. Medical Oncology. 2002;19(3):141–52.
• Bhutani M, Kumar L, Vora A, Bhardwaj N, Pathak AK, Singh R, et al. Randomized study comparing 4?-epi-doxorubicin (Epirubicin) versus doxorubicin as a part of induction treatment in adult acute lymphoblastic leukemia. American Journal of Hematology. 2002 Nov 22;71(4):241–7.
• Seth T, Vora A, Bhutani M, Ganessan K, Jain P, Kumar R, et al. Acute Basophilic Leukemia with t(8;21). Leukemia & Lymphoma. 2004 Mar;45(3):605–8

• European Society of Medical Oncology
• Indian Co operative Oncology Network
• Indian Society of Medical and Paediatric Oncology
• Mumbai Hematology Group

• Consultant - PSRI Hospital
• Consultant - Jeewan Hospital, Maharani Bagh
• Associate Professor - Tata Memorial Hospital, Mumbai
• HOD - Max Saket
• Registrar - AIIMS, New Delhi
• Founder - HOPE Oncology Clinic
• HOD - W Pratiksha Hospital
• Senior Consultant - Max Health Care
• Assistant Professor - Tata Memorial Centre